141 related articles for article (PubMed ID: 37990583)
1. Paediatric hypertrophic cardiomyopathy secondary to Danon disease.
Tang K; Wu J; Liu X; Wang S
Cardiol Young; 2024 Jan; 34(1):201-204. PubMed ID: 37990583
[TBL] [Abstract][Full Text] [Related]
2. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease.
Türkmen H; Uysal F; Bostan ÖM
Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912
[TBL] [Abstract][Full Text] [Related]
3. [Danon disease: a case report and literature overview].
Catović S; Otasević P
Srp Arh Celok Lek; 2007; 135(3-4):197-200. PubMed ID: 17642461
[TBL] [Abstract][Full Text] [Related]
4. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy.
Dougu N; Joho S; Shan L; Shida T; Matsuki A; Uese K; Hirono K; Ichida F; Tanaka K; Nishino I; Inoue H
Circ J; 2009 Feb; 73(2):376-80. PubMed ID: 19057086
[TBL] [Abstract][Full Text] [Related]
5. Danon disease presenting with early onset of hypertrophic cardiomyopathy and peripheral pigmentary retinal dystrophy in a female with a
Meinert M; Englund E; Hedberg-Oldfors C; Oldfors A; Kornhall B; Lundin C; Wittström E
Ophthalmic Genet; 2019 Jun; 40(3):227-236. PubMed ID: 31264915
[No Abstract] [Full Text] [Related]
6. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease.
Kim H; Cho A; Lim BC; Kim MJ; Kim KJ; Nishino I; Hwang YS; Chae JH
Muscle Nerve; 2010 Jun; 41(6):879-82. PubMed ID: 20513107
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience.
Jhaveri S; Herber J; Zahka K; Boyle GJ; Saarel EV; Aziz PF
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1932-1938. PubMed ID: 31240821
[TBL] [Abstract][Full Text] [Related]
8. Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene.
Sugie K; Yoshizawa H; Onoue K; Nakanishi Y; Eura N; Ogawa M; Nakano T; Sakaguchi Y; Hayashi YK; Kishimoto T; Shima M; Saito Y; Nishino I; Ueno S
Neuropathology; 2016 Dec; 36(6):561-565. PubMed ID: 27145725
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report.
Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M
BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794
[TBL] [Abstract][Full Text] [Related]
10. Progression of Danon disease with medical imaging: two case reports.
Wang S; Wang Q; Zhai N; Wang X; Li Z; Gan L; Cui Y
J Int Med Res; 2021 Feb; 49(2):300060520986676. PubMed ID: 33530800
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of Danon disease: Flow cytometric detection of lysosome-associated membrane protein-2-negative leukocytes.
Hashida Y; Wada T; Saito T; Ohta K; Kasahara Y; Yachie A
J Cardiol; 2015 Aug; 66(2):168-74. PubMed ID: 25458169
[TBL] [Abstract][Full Text] [Related]
12. Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation.
Cottinet SL; Bergemer-Fouquet AM; Toutain A; Sabourdy F; Maakaroun-Vermesse Z; Levade T; Chantepie A; Labarthe F
J Inherit Metab Dis; 2011 Apr; 34(2):515-22. PubMed ID: 21161685
[TBL] [Abstract][Full Text] [Related]
13. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.
Zaki A; Zaidi A; Newman WG; Garratt CJ
J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876
[TBL] [Abstract][Full Text] [Related]
14. Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry.
López-Sainz Á; Salazar-Mendiguchía J; García-Álvarez A; Campuzano Larrea O; López-Garrido MÁ; García-Guereta L; Fuentes Cañamero ME; Climent Payá V; Peña-Peña ML; Zorio-Grima E; Jordá-Burgos P; Díez-López C; Brugada R; García-Pinilla JM; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):479-486. PubMed ID: 30108015
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance imaging in Danon disease.
Nucifora G; Miani D; Piccoli G; Proclemer A
Cardiology; 2012; 121(1):27-30. PubMed ID: 22378182
[TBL] [Abstract][Full Text] [Related]
16. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.
Fanin M; Nascimbeni AC; Fulizio L; Spinazzi M; Melacini P; Angelini C
Am J Pathol; 2006 Apr; 168(4):1309-20. PubMed ID: 16565504
[TBL] [Abstract][Full Text] [Related]
17. Danon disease as a cause of autophagic vacuolar myopathy.
Yang Z; Vatta M
Congenit Heart Dis; 2007; 2(6):404-9. PubMed ID: 18377432
[TBL] [Abstract][Full Text] [Related]
18. A rare phenotype of heterozygous Danon disease mimicking apical hypertrophic cardiomyopathy.
Yu L; Wan K; Han Y; Chen Y
Eur Heart J; 2018 Sep; 39(34):3263-3264. PubMed ID: 29240871
[No Abstract] [Full Text] [Related]
19. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J
Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667
[TBL] [Abstract][Full Text] [Related]
20. Gene symbol: LAMP2. Disease: Danon disease.
Iascone M; Iacovoni A; Marchetti D; Ferrazzi P
Hum Genet; 2008 Jun; 123(5):537. PubMed ID: 20960602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
